Patent details

Basic Information

Publication number:

EP3307323

PCT Application Number:

IL2016050624

Type:

European Patent Granted for LU

Legal Status:

Lapsed

Application number:

EP167388834

PCT Publication Number:

WO2016203468

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

CARBAZOLE DERIVATIVES FOR THE TREATMENT OF FIBROTIC DISEASES AND RELATED SYMPTOMS, AND CONDITIONS THEREOF

French Title of Invention:

DÉRIVÉ DE CARBAZOLE POUR LE TRAITEMENT DES MALADIES FIBROTIQUES, DES SYMPTÔMES ASSOCIÉS, ET DES AFFECTIONS EN DÉCOULANT

German Title of Invention:

CARBAZOL-DERIVATE ZUR BEHANDLUNG FIBROTISCHER ERKRANKUNGEN UND VERWANDTER SYMPTOME SOWIE VON ZUSTÄNDEN DAVON

SPC Number:

Dates

Filing date:

14/06/2016

Grant date:

13/07/2022

EP Publication Date:

18/04/2018

PCT Publication Date:

22/12/2016

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

13/07/2022

EP B1 Publication Date:

13/07/2022

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

14/06/2023

Expiration date:

14/06/2036

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

06/07/2022

 

 

Name:

Raziel Therapeutics Ltd.

Address:

10 Prof. Menachem Plaut Street, 7670609 Rehovot, Israel (IL)

Inventor

Name:

BEN-SASSON, Shmuel

Address:

Israel (IL)

Priority

Priority Number:

201562175552 P

Priority Date:

15/06/2015

Priority Country:

United States (US)

Classification

IPC classification:

A61K 45/06; A61K 31/403; A61P 17/02; A61P 43/00;

Publication

European Patent Bulletin

Issue number:

202228

Publication date:

13/07/2022

Description:

Grant (B1)

Annual Fees

Annual Fee Due Date:

Annual Fee Number:

Expected Payer:

Last Annual Fee Payment Date:

Last Annual Fee Paid Number:

Payer:

Filing date	Document type	Number of pages